Inspira(TM) Technologies Begins Manufacturing of the ALICE(TM) CPB Device, ahead of planned 2023 FDA submission

Stock Information for Inspira Technologies Oxy B.H.N. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inspira Technologies Oxy B.H.N. Ltd.

Inspira(TM) Signs Term Sheet for Use of INSPIRA(TM) ART100 Device in Organ Transplant Procedures
Inspira(TM) and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
Inspira(TM) Announces Program to Pioneer the Applicable Use of the INSPIRA(TM) ART100 Device for an Artificial Womb
Inspira(TM) Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
Inspira(TM) Technologies Reports Full Year 2023 Financial Results
Inspira(TM) Announces AMAR Regulatory Submission of the INSPIRA(TM) ART100, to Enter the Southeast Asia and South American Markets
Inspira(TM) Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
Inspira(TM) Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.